{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"NanoViricides, Inc."},"Symbol":{"label":"Symbol","value":"NNVC"},"Address":{"label":"Address","value":"1 CONTROLS DRIVE, SHELTON, Connecticut, 06484, United States"},"Phone":{"label":"Phone","value":"+1 203 937-6137"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy."},"CompanyUrl":{"label":"Company Url","value":"http://www.nanoviricides.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anil R. Diwan","title":"Executive Chairman, President & CEO"},{"name":"Jayant Tatake","title":"Vice President-Research & Development"},{"name":"Randall W. Barton","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}